API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207381
https://www.fiercepharma.com/pharma/sanofi-blocks-sandoz-jevtana-generic-patent-win
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207693
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharmas-partner-breckenridge-pharmaceutical-gets-fda-nod-for-prostate-cancer-treatment-drug/articleshow/93103041.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207693
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207736
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207718
https://www.prnewswire.com/news-releases/starpharma-releases-positive-dep-phase-2-interim-results-in-prostate-cancer-301432299.html
https://www.clinicaltrialsarena.com/news/starpharma-interim-data-prostate-cancer/
https://www.fiercebiotech.com/biotech/astrazeneca-wields-ax-scrapping-midphase-programs-from-1b-takeover-heptares-pact-latest
https://www.prnewswire.com/news-releases/us-patent-and-trademark-office-grants-new-patent-for-dep-cabazitaxel-one-of-starpharmas-phase-2-clinical-stage-cancer-treatments-301377264.html
http://www.news.sanofi.us/2019-09-30-New-England-Journal-of-Medicine-publishes-data-showing-improved-survival-with-Jevtana-R-cabazitaxel-over-second-androgen-receptor-targeted-agent-in-metastatic-castration-resistant-prostate-cancer
https://www.patentdocs.org/2019/08/sanofi-aventis-us-llc-v-dr-reddys-laboratories-inc-fed-cir-2019.html
https://www.fiercepharma.com/pharma/defending-its-top-oncology-drug-sanofi-wins-jevtana-patent-challenge
http://www.pmlive.com/pharma_news/sanofi_patent_case_win_holds_off_generic_rivals_for_key_cancer_drug_1297761
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207736
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207735
http://www.fiercepharma.com/pharma/swayed-by-a-discount-nice-backflips-sanofi-gaucher-med-cerdelga-0
http://www.thehindubusinessline.com/companies/article9547318.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207736
http://www.nasdaq.com/article/scottish-medicines-consortium-okays-sanofi-prostate-cancer-drug-20161212-01050#ixzz4ShH1UhJu
https://www.pharmacompass.com/pdf/news/accords-genericcabazitaxel-receives-tentative-approval-in-us-1477649787.pdf
http://www.prnewswire.com/news-releases/oncogenex-announces-phase-3-affinity-trial-with-custirsen-continues-following-interim-analyses-300186319.html
http://www.pmlive.com/pharma_news/patient_survey_finds_pharma_falls_short_on_drug_pricing_753042
http://www.pharmatimes.com/Article/15-05-26/Sanofi_s_Jevtana_given_last-minute_CDF_reprieve.aspx
http://www.bpirx.com/html/index.aspx?p32sda=newsArchive&psdge87d=302&tl97abi=82&nsd=63
http://natcopharma.co.in/index.php/news-for-dump/195-NATCO-announces-USFDA-Filings-for-Fingolimod
http://www.telegraph.co.uk/news/politics/11340860/25-cancer-drugs-to-be-denied-on-NHS.html